7th RSC-BMCS / DMDG New Perspectives in DMPK and Medicinal Chemistry
Event
7th RSC-BMCS / DMDG New Perspectives in DMPK and Medicinal Chemistry
Date
Wednesday 10th June, 2026
Place
Burlington House, London
Important links and downloads
Social media hashtag – #DMPK26
To submit an Abstract, please click here
To register to attend the meeting, please click here
To sponsor or exhibit at the meeting, please click here
To download the third announcement poster, please click here
Synopsis
We are excited to return for our 7th New Perspectives meeting jointly organised between the RSC and DMDG. This year we have selected 2 hot topics which the organising committee feel will be of great interest to members of both groups. Firstly antibody drug conjugates continue to show considerable promise and we will have a series of talks focussing on latest developments in the field. Secondly we will focus on biocatalysis making use of the overlapping expertise between the DMPK biotransformation knowledge and the chemists’ experience of novel synthetic routes.
This meeting is a great opportunity to interact with scientists and experts from a different learned society and we look forward to welcoming many of you to London in June.
Confirmed Speakers
Adriana Savoca, Astra Zeneca
Integration of clinical data and mechanistic model simulations highlights key DMPK parameters for design and selection of successful ADCs
Maria Chatzopoulou, UCB
Tools for the structural elucidation of metabolites and applications in drug discovery workflows
Who should attend
Medicinal chemists, drug discovery scientists, pharmacologists, toxicologists, DMPK scientists – from academia, industry, and third sector institutions.
Want to know more?
Call for Abstracts
Abstract Submission is now closed
Registration Fees
Registration is now open! Click here to register
Member £200
Non-member £250
Student Member £100
Student Non-member £150
Member is a full member of the RSC or the DMDG
Student rates apply to undergraduate post-graduate and post-doctoral students
Want to become a member?
To join the RSC and in order to qualify for discounted registration fees, please click here
To join the DMDG and in order to qualify for discounted registration fees, please click here
Programme
| 08:30 | Registration Open |
|---|---|
| 09:00 | Poster viewing and arrival refreshments |
| 10:00 | Opening Remarks Hugh Walton, Astex Pharmaceuticals and Lewis Burton, Sygnature Discovery |
| Session 1: ADC's Session Chairs: Hugh Walton, Astex Pharmaceuticals and Lewis Burton, Sygnature Discovery |
|
| 10:10 | Integration of clinical data and mechanistic model simulations highlights key DMPK parameters for design and selection of successful ADCs Adriana Savoca, Astra Zeneca |
| 10:55 | Changing the ADC paradigm – what does the future hold? Allan Jordan, Sygnature Discovery |
| 11:25 | Comprehensive LC-MS workflows for antibody drug conjugate (ADC) analysis Cathy Lane, SCIEX |
| 11:55 | Quantitative Subcellular Pharmacokinetics Across Modalities (QIPK): A Label-Free Platform for Intracellular DMPK Tom Schirris, QTM BioSciences |
| 12:25 | Lunch, exhibition and posters |
| Session 2: Biocatalysis Session Chair: Andrew Stachulski, University of Liverpool |
|
| 13:30 | Tools for the structural elucidation of metabolites and applications in drug discovery workflows Maria Chatzopoulou, UCB |
| 14:15 | Beyond Chemistry and DMPK: development of a biocatalytic toolkit for fragment-based drug discovery (FBDD) Wojciech Zawodny, Astex Pharmaceuticals |
| 14:45 | Integrated Metabolite Identification and Biocatalytic Synthesis: Case Studies with Repaglinide and PROTAC MZ-1 Liam Evans, Hypha Discovery |
| 15:15 | Refreshments, exhibition and poster session |
| Session 3 Session Chair: Cathy Lane, SCIEX |
|
| 15:45 | Improving drug metabolism outcomes with mechanistic in silico modelling Matthew Segall, Optibrium Limited |
| 16:15 | Identification of the Metabolites of ART26.12, a clinical stage Fatty Acid Binding Protein 5 Inhibitor Myles Osborn, Artelo Biosciences |
| 16:45 | Exploring Trends in Metabolism: Insights from the Meteor Nexus Database Samuel Boobier, Lhasa Limited |
| 17:15 | Closing Remarks |
| Hugh Walton, Astex Pharmaceuticals and Lewis Burton, Sygnature Discovery |
Sponsorship/Exhibition Opportunities
Bookings to sponsor or exhibit at the meeting are now open, please click here to book.
Sorry our exhibitor stands have now sold out. To be added to the waitlist for an exhibition stand, please email charlotte.turpin@hg3.co.uk. Or alternatively, we would welcome any sponsorship you can give.
Exhibition Package (£750) includes:
– One stand personnel with access to technical sessions
– A six-foot trestle table and chair(s)
– Electrical and Wi-Fi access
– Your logo on the meetings’ website page
– Your logo and full promotional page in the pdf of the delegate handbook
– Your logo in the rolling slides, shown during the breaks
– Any additional stand personnel will have to be booked as delegates
Sponsorship of lanyards (£500):
All delegates will be given a lanyard to hold their name badge on arrival with your company’s logo on arrival. Sponsoring the lanyards will ensure that delegates have your company name on them at all times and will therefore provide a high profile sponsorship option throughout the duration of the conference. In addition, your company logo and website link will also be displayed on the conference website.
We are also seeking sponsorship (minimum £250) from organisations to support the meeting. You can support and sponsor the meeting by clicking here
Sponsorship includes:
-Your logo in the pre-event announcements
-Your logo in the pdf of the delegate handbook
-Your logo in the rolling slides, shown during the breaks
-Your logo included in the communication email to delegates
Confirmed Exhibitors
We are grateful to our confirmed exhibitors for their valued support.
Organising Committee
Lewis Burton, Sygnature Discovery
Cathy Lane, SCIEX
Andrew Stachulski, Liverpool University (Chair)
Hugh Walton, Astex Pharmaceuticals
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
Email
